HIF‐2α induction, by contrast, has been shown to counteract HIF‐1α‐dependent cell cycle arrest in renal cell carcinoma lines, thereby resulting in enhanced proliferation dependent on c‐Myc gain‐of‐function (Gordan et al, 2007). Here, EPAS1 is linked to hereditary clear cell renal cell carcinoma.